Hambrecht & Quist Capital Management

Hambrecht & Quist Capital Management is a venture capital firm in Boston that invests in early and late stage ventures. Founded 1968 in Boston, Massachusetts, United States by William R. Timken, the company is also known as Tekla Capital Management LLC. Its portfolio companies include Veniti, Tibion Bionic Technologies, Euthymics Bioscience, CardioKinetix, FlowCardia, TargeGen, Xanthus Pharmaceuticals, Raven Biotechnologies and Corus Pharma. As of January 2020, the company had 24 exits and 40 investments. The company manages two closed-end equity funds, H&Q Healthcare Investors and H&Q Life Sciences Investors. The Funds invest in growth equities, both public and private, in the healthcare and life sciences industries.